World's Best Scientists 2026 revealed!
Shiv Pillai

Shiv Pillai

D-Index & Metrics

Immunology

D-Index
70
Citations
22639
World Ranking
2383
National Ranking
1140

Shiv Pillai publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shiv Pillai sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 293 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Shiv Pillai D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shiv Pillai sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Shiv Pillai is a researcher affiliated with MIT in the United States with a focus on medicine, immunology, and microbiology. Their work spans multiple subfields including immunology, infectious diseases, molecular biology, rheumatology, and surgery. The scientist's research primarily addresses immunological mechanisms with special attention to T-cell and B-cell immunology, SARS-CoV-2 and COVID-19, immunodeficiency and autoimmune disorders, and immune cell function and interaction. Other notable topics include IgG4-related and inflammatory diseases as well as immunotherapy and immune responses.

Among recent publications attributed to research closely related or co-authored in their field, key papers include:

  • Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 (2020, Cell)
  • Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier (2021, Journal of Clinical Investigation)
  • Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis (2020, Journal of Clinical Investigation)
  • SnapShot: COVID-19 (2020, Cell)
  • CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease (2020, Journal of Allergy and Clinical Immunology)

Frequent co-authors who have collaborated extensively with Shiv Pillai include Cory A. Perugino, Vinay S. Mahajan, Naoki Kaneko, Hang Liu, and Hugues Allard-Chamard.

The venues where they have frequently published include:

  • Science Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Allergy and Clinical Immunology
  • Annals of the Rheumatic Diseases
  • SSRN Electronic Journal

Shiv Pillai's contribution to the scientific community is concentrated on advancing understanding in immunology and related diseases, particularly those involving T-cell mediated processes and inflammatory responses. Their work on COVID-19 and associated immune mechanism disruptions reflects a significant engagement with contemporary infectious disease challenges.

Best Publications

  • Galectins: a family of animal beta-galactoside-binding lectins.

    Samuel H. Barondes;Vincent Castronovo;Douglas N W Cooper;Richard D. Cummings

  • IgG4-related disease

    Terumi Kamisawa;Yoh Zen;Shiv Pillai;John H Stone

  • SARS-CoV-2 viral load is associated with increased disease severity and mortality.

    Jesse Fajnzylber;James Regan;Kendyll Coxen;Heather Corry

  • MARGINAL ZONE B CELLS

    Shiv Pillai;Annaiah Cariappa;Stewart T. Moran

  • The follicular versus marginal zone B lymphocyte cell fate decision

    Shiv Pillai;Annaiah Cariappa

  • Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.

    Naoki Kaneko;Hsiao-Hsuan Kuo;Julie Boucau;Jocelyn R. Farmer

  • Peripheral B cell subsets

    David Allman;Shiv Pillai

  • IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.

    Zachary S. Wallace;Vikram Deshpande;Hamid Mattoo;Vinay S. Mahajan

  • Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations

    Zachary S Wallace;Hamid Mattoo;Mollie Carruthers;Vinay S Mahajan

  • The Follicular versus Marginal Zone B Lymphocyte Cell Fate Decision Is Regulated by Aiolos, Btk, and CD21

    Annaiah Cariappa;Mei Tang;Chuenlei Parng;Eugene Nebelitskiy

  • Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease

    Hamid Mattoo;Vinay S. Mahajan;Takashi Maehara;Vikram Deshpande

  • De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease

    Hamid Mattoo;Vinay S. Mahajan;Emanuel Della-Torre;Yurie Sekigami

  • IgG4-related disease.

    Mahajan Vs;Mattoo H;Deshpande;Pillai Ss

  • Siglecs and Immune Regulation

    Shiv Pillai;Ilka Arun Netravali;Annaiah Cariappa;Hamid Mattoo

  • B lymphocytes and cancer: a love-hate relationship.

    Grace J. Yuen;Ezana Demissie;Shiv Pillai

  • Aiolos regulates B cell activation and maturation to effector state

    Jin-Hong Wang;Nicole Avitahl;Annaiah Cariappa;Christof Friedrich

  • The Mac-2 antigen is a galactose-specific lectin that binds IgE.

    B. J. Cherayil;Saul J. Weiner;S. Pillai

  • Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice

    Diana M. Brainard;Edward Seung;Nicole Frahm;Nicole Frahm;Annaiah Cariappa

  • Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease

    E. Della Torre;E. Della Torre;H. Mattoo;V. S. Mahajan;M. Carruthers

  • NK T cells provide lipid antigen-specific cognate help for B cells

    Elizabeth A. Leadbetter;Manfred Brigl;Petr Illarionov;Nadia Cohen

Frequent Co-Authors

Andrew H. Lichtman
Andrew H. Lichtman Brigham and Women's Hospital
Abul K. Abbas
Abul K. Abbas University of California, San Francisco
John H. Stone
John H. Stone Harvard University
Vikram Deshpande
Vikram Deshpande Harvard University
Bruce D. Walker
Bruce D. Walker Harvard University
Kurt J. Isselbacher
Kurt J. Isselbacher Harvard University
Angelo A. Manfredi
Angelo A. Manfredi Vita-Salute San Raffaele University
Jolan E. Walter
Jolan E. Walter University of South Florida
Massimo Falconi
Massimo Falconi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, often requiring specialized nursing qualifications. Many professionals consider advancing their nursing education through programs like accelerated FNP programs, which allow registered nurses to fast-track into Family Nurse Practitioner roles, combining clinical expertise with immunological knowledge.

For nurses already practicing as Family Nurse Practitioners, transitioning to more specialized roles such as an Acute Care Nurse Practitioner is a strategic step to deepen clinical focus. Guidance on how to make this shift can be found under FNP to ACNP, outlining the necessary credentials and experience.

Many aspiring nurses without prior experience can start their journey through online RN programs for non nurses, designed to build foundational skills aligned with immunological studies and patient care. These programs also provide flexible options for those balancing work and education.

Understanding financial prospects is crucial. For instance, exploring DNP salary transparency helps students and professionals evaluate return on investment across different states, ensuring informed career decisions within the immunology and nursing fields.

Best Scientists Citing Shiv Pillai

Trending Scientists

Recently Published Articles